What is Yonalink?
Yonalink is developing a sophisticated platform designed to automate the migration of clinical research data from electronic health records in medical centers to secure research databases. The company emphasizes an automated, secure, validated, trusted, and error-free process, aiming to streamline critical data workflows within the healthcare and research sectors. This focus on data integrity and efficiency positions Yonalink as a key player in enhancing the reliability and speed of clinical research.
How much funding has Yonalink raised?
Yonalink has raised a total of $6M across 1 funding round:
Other Financing Round
$6M
Other Financing Round (2022): $6M with participation from European Union, Debiopharm Innovation Fund, and eHealth Ventures
Key Investors in Yonalink
European Union
The European Union, a political and economic union of European countries, often supports initiatives that foster societal progress and technological advancement, particularly in areas of public health and research.
Debiopharm Innovation Fund
Debiopharm Innovation Fund is an investment arm likely focused on backing innovative ventures within the pharmaceutical and healthcare sectors, potentially driving advancements in medical research and treatment.
eHealth Ventures
eHealth Ventures is an early-stage digital health fund that focuses on optimizing venture building through strategic healthcare partnerships and a skilled professional team. The company supports clinical integration, business validation, and commercial expansion for its portfolio companies.
What's next for Yonalink?
With this substantial enterprise-level backing, Yonalink is poised for significant expansion and further development of its data migration technology. The strategic investment will likely fuel enhancements to the platform's capabilities, broaden its market reach, and strengthen its position within the competitive digital health landscape. The company's trajectory suggests a focus on scaling operations and solidifying partnerships to accelerate the adoption of its validated data solutions in clinical research.
See full Yonalink company page
